ADMA Biologics Other Long Term Liabilities (Quarterly) Trends

ADMA Biologics, Inc. (ADMA)

17.98 +0.28 (+1.61%) USD | NASDAQ | Jan 14, 14:26

View Other Long Term Liabilities (Quarterly) for ADMA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Vanda Pharmaceuticals, Inc.	Upgrade
Aldeyra Therapeutics, Inc.	--
Arcutis Biotherapeutics, Inc.	Upgrade
Marker Therapeutics, Inc.	--
CorMedix, Inc.	--